Feb 24, 2026Estrogen, Menopause, and Aging: Hormonal Mechanisms, Health Implications, and ProtocolMenopause-associated estrogen decline drives accelerated changes in cardiovascular risk, bone density, cognitive function, and metabolic health. Menopausal hormone therapy (MHT) has RCT and observational evidence supporting benefits for symptomatic relief and bone protection; cardiovascular and breast cancer risks depend on timing, type, and route of administration.
Jan 29, 2026Bone Density Decline: D3, K2, Protein, Weight-Bearing Exercise, and DEXA MonitoringBone density peaks in the late 20s and declines gradually — accelerating in women after menopause. An evidence-based protocol combines adequate calcium, vitamin D3, vitamin K2, and protein with weight-bearing exercise and regular DEXA monitoring.